{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Thankamony AP"],"funding":["Science and Engineering Research Board"],"pagination":["1230647"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10570535"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13"],"pubmed_abstract":["The triple negative breast cancer (TNBC) subtype is one of the most aggressive forms of breast cancer that has poor clinical outcome and is an unmet clinical challenge. Accumulating evidence suggests that intratumoral heterogeneity or the presence of phenotypically distinct cell populations within a tumor play a crucial role in chemoresistance, tumor progression and metastasis. An increased understanding of the molecular regulators of intratumoral heterogeneity is crucial to the development of effective therapeutic strategies in TNBC. To this end, we used an unbiased approach to identify a molecular mediator of intratumoral heterogeneity in breast cancer by isolating two tumor cell populations (T1 and T2) from the 4T1 TNBC model. Phenotypic characterization revealed that the cells are diff"],"journal":["Frontiers in oncology"],"pubmed_title":["Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer."],"pmcid":["PMC10570535"],"funding_grant_id":["SB/S2/RJN/182/2014"],"pubmed_authors":["Ramkomuth S","Murali R","Swarbrick A","Karthikeyan N","Jolly MK","Ramesh ST","Chakraborty P","Jaikumar VS","Thankamony AP","Nair R","Varghese BA"],"additional_accession":[]},"is_claimable":false,"name":"Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer.","description":"The triple negative breast cancer (TNBC) subtype is one of the most aggressive forms of breast cancer that has poor clinical outcome and is an unmet clinical challenge. Accumulating evidence suggests that intratumoral heterogeneity or the presence of phenotypically distinct cell populations within a tumor play a crucial role in chemoresistance, tumor progression and metastasis. An increased understanding of the molecular regulators of intratumoral heterogeneity is crucial to the development of effective therapeutic strategies in TNBC. To this end, we used an unbiased approach to identify a molecular mediator of intratumoral heterogeneity in breast cancer by isolating two tumor cell populations (T1 and T2) from the 4T1 TNBC model. Phenotypic characterization revealed that the cells are diff","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2026-07-14T22:03:17.751Z","creation":"2025-04-06T02:00:41.509Z"},"accession":"S-EPMC10570535","cross_references":{"pubmed":["37841442"],"doi":["10.3389/fonc.2023.1230647"]}}